Details.
Provides assistance for Edurant, Prezcobix, Prezista, and Symtuza. Financial eligibility is 300% FPL. The uninsured program is operated through the Johnson & Johnson Patient Assistance Foundation, while the insured program is operated through Janssen Pharmaceuticals.